JP2017520528A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017520528A5 JP2017520528A5 JP2016568605A JP2016568605A JP2017520528A5 JP 2017520528 A5 JP2017520528 A5 JP 2017520528A5 JP 2016568605 A JP2016568605 A JP 2016568605A JP 2016568605 A JP2016568605 A JP 2016568605A JP 2017520528 A5 JP2017520528 A5 JP 2017520528A5
- Authority
- JP
- Japan
- Prior art keywords
- unsubstituted
- alkyl
- substituted
- substituent
- halogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462001188P | 2014-05-21 | 2014-05-21 | |
| US62/001,188 | 2014-05-21 | ||
| PCT/US2015/032069 WO2015179707A1 (en) | 2014-05-21 | 2015-05-21 | Imidazole derivatives as formyl peptide receptor modulators |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017520528A JP2017520528A (ja) | 2017-07-27 |
| JP2017520528A5 true JP2017520528A5 (https=) | 2018-07-05 |
| JP6660889B2 JP6660889B2 (ja) | 2020-03-11 |
Family
ID=53276329
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016568605A Expired - Fee Related JP6660889B2 (ja) | 2014-05-21 | 2015-05-21 | ホルミルペプチド受容体調節物質としてのイミダゾール誘導体 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US10301269B2 (https=) |
| EP (1) | EP3145916B1 (https=) |
| JP (1) | JP6660889B2 (https=) |
| KR (1) | KR20170005121A (https=) |
| CN (1) | CN106458921B (https=) |
| AU (2) | AU2015264021B2 (https=) |
| BR (1) | BR112016027133A8 (https=) |
| CA (1) | CA2948876A1 (https=) |
| DK (1) | DK3145916T3 (https=) |
| ES (1) | ES2788700T3 (https=) |
| RU (1) | RU2748652C2 (https=) |
| WO (1) | WO2015179707A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12478503B2 (en) | 2009-05-18 | 2025-11-25 | Glaukos Corporation | Implants with controlled drug delivery features and methods of using same |
| US10206813B2 (en) | 2009-05-18 | 2019-02-19 | Dose Medical Corporation | Implants with controlled drug delivery features and methods of using same |
| CN106518742B (zh) | 2011-10-26 | 2020-01-21 | 阿勒根公司 | 作为甲酰肽受体样-1(fprl-1)受体调节剂的n-脲取代的氨基酸的酰胺衍生物 |
| BR112015021392B1 (pt) * | 2013-03-06 | 2021-11-16 | Allergan, Inc | Uso de agonistas do receptor de peptídeo formil 2 para tratar doenças dermatológicas |
| RU2703725C1 (ru) | 2013-11-21 | 2019-10-22 | Аллерган, Инк. | Производные фенилкарбамата в качестве модуляторов формилпептидного рецептора |
| CA2948876A1 (en) | 2014-05-21 | 2015-11-26 | Allergan, Inc. | Imidazole derivatives as formyl peptide receptor modulators |
| EP3442950A1 (en) * | 2016-04-12 | 2019-02-20 | Allergan, Inc. | Phenyl urea derivatives as n-formyl peptide receptor modulators |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2533210A1 (fr) | 1982-09-17 | 1984-03-23 | Lyon I Universite Claude | Edulcorants de synthese |
| EP1692502A2 (en) | 2003-11-07 | 2006-08-23 | Acadia Pharmaceuticals Inc. | Use of the lipoxin receptor, fprl1, as a tool for identifying compounds effective in the treatment of pain and inflammation |
| BRPI0506662B8 (pt) | 2004-01-06 | 2021-05-25 | Novo Nordisk As | compostos ativadores de glucoquinase |
| WO2007086584A1 (ja) * | 2006-01-30 | 2007-08-02 | Meiji Seika Kaisha, Ltd. | 新規ＦａｂＫおよびＦａｂＩ／Ｋ阻害剤 |
| AU2007287428B2 (en) * | 2006-08-24 | 2011-08-11 | Astrazeneca Ab | Morpholino pyrimidine derivatives useful in the treatment of proliferative disorders |
| WO2009000748A1 (en) | 2007-06-27 | 2008-12-31 | Solvay Fluor Gmbh | Preparation of compounds with a perfluoroalkylsulfonyl group |
| AU2008273889B2 (en) * | 2007-07-09 | 2012-03-08 | Astrazeneca Ab | Trisubstituted pyrimidine derivatives for the treatment of proliferative diseases |
| CN101998680B (zh) * | 2009-08-24 | 2016-01-13 | 中兴通讯股份有限公司 | 帧序列号的发送方法及节点b和服务无线网络控制器 |
| WO2012074785A1 (en) | 2010-12-03 | 2012-06-07 | Allergan, Inc. | Pharmaceutical compositions comprising 3,4- dihydroisoquinolin-2(1 h)-yl-3-phenylurea derivatives having formyl peptide receptor like-1 (fprl-1) agonist or antagonist activity |
| AU2012214265A1 (en) | 2011-02-11 | 2013-09-05 | Allergan, Inc. | Novel 1-(1-oxo-1,2,3,4-tetrahydroisoquinolin-7-yl)urea derivatives as N-formyl peptide receptor like-1 (FPRL-1) receptor modulators |
| EP2731931A1 (en) | 2011-07-11 | 2014-05-21 | Allergan, Inc. | Polycyclic pyrrolidine-2,5-dione derivatives as -formyl peptide receptor like-1 (fprl-1) receptor modulators |
| CN106518742B (zh) | 2011-10-26 | 2020-01-21 | 阿勒根公司 | 作为甲酰肽受体样-1(fprl-1)受体调节剂的n-脲取代的氨基酸的酰胺衍生物 |
| US8541577B2 (en) | 2011-11-10 | 2013-09-24 | Allergan, Inc. | Aryl urea derivatives as N-formyl peptide receptors like-1 (FPRL-1) receptor modulators |
| US8492556B2 (en) * | 2011-11-10 | 2013-07-23 | Allergan, Inc. | 2,5-Dioxoimidazolidin-1-yl-3-phenylurea derivatives as formyl peptide receptor like-1 (FPRL-1) receptor modulators |
| CA2864893A1 (en) * | 2012-02-16 | 2013-08-22 | Allergan, Inc. | Imidazolidine-2,4-dione derivatives as n-formyl peptide receptor 2 modulators |
| SG11201406629VA (en) | 2012-04-16 | 2014-11-27 | Allergan Inc | (2-ureidoacetamido)alkyl derivatives as formyl peptide receptor 2 modulators |
| BR112015021392B1 (pt) | 2013-03-06 | 2021-11-16 | Allergan, Inc | Uso de agonistas do receptor de peptídeo formil 2 para tratar doenças dermatológicas |
| BR122017004254B1 (pt) | 2013-03-06 | 2021-04-13 | Allergan, Inc. | Uso de agonistas de receptor de formil peptídeo 2 para tratar doenças inflamatórias oculares |
| WO2015009545A1 (en) | 2013-07-16 | 2015-01-22 | Allergan, Inc. | Derivatives of n-urea substituted amino acids as formyl peptide receptor modulators |
| RU2703725C1 (ru) | 2013-11-21 | 2019-10-22 | Аллерган, Инк. | Производные фенилкарбамата в качестве модуляторов формилпептидного рецептора |
| WO2015116574A1 (en) | 2014-01-29 | 2015-08-06 | Allergan, Inc. | Urea hydantoin derivatives as formyl peptide modulators |
| WO2015116566A1 (en) | 2014-01-29 | 2015-08-06 | Allergan, Inc. | 2,5-dioxoimidazolidin-1-yl-3-urea derivatives as formyl peptide modulators |
| US9663457B2 (en) | 2014-04-09 | 2017-05-30 | Allergan, Inc. | Carbamoyl hydrazine derivatives as formyl peptide modulators |
| CA2948876A1 (en) | 2014-05-21 | 2015-11-26 | Allergan, Inc. | Imidazole derivatives as formyl peptide receptor modulators |
| CN109715602A (zh) | 2016-03-28 | 2019-05-03 | 阿勒根公司 | 苯基脲衍生物作为n-甲酰肽受体调节剂 |
| EP3442950A1 (en) | 2016-04-12 | 2019-02-20 | Allergan, Inc. | Phenyl urea derivatives as n-formyl peptide receptor modulators |
-
2015
- 2015-05-21 CA CA2948876A patent/CA2948876A1/en not_active Abandoned
- 2015-05-21 RU RU2016145596A patent/RU2748652C2/ru active
- 2015-05-21 DK DK15726498.7T patent/DK3145916T3/da active
- 2015-05-21 CN CN201580026983.9A patent/CN106458921B/zh active Active
- 2015-05-21 US US15/312,367 patent/US10301269B2/en active Active
- 2015-05-21 WO PCT/US2015/032069 patent/WO2015179707A1/en not_active Ceased
- 2015-05-21 EP EP15726498.7A patent/EP3145916B1/en active Active
- 2015-05-21 KR KR1020167035670A patent/KR20170005121A/ko not_active Ceased
- 2015-05-21 AU AU2015264021A patent/AU2015264021B2/en not_active Ceased
- 2015-05-21 JP JP2016568605A patent/JP6660889B2/ja not_active Expired - Fee Related
- 2015-05-21 ES ES15726498T patent/ES2788700T3/es active Active
- 2015-05-21 BR BR112016027133A patent/BR112016027133A8/pt not_active Application Discontinuation
-
2019
- 2019-05-22 US US16/419,317 patent/US10800744B2/en active Active
-
2020
- 2020-05-25 AU AU2020203420A patent/AU2020203420B2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017520528A5 (https=) | ||
| RU2016145596A (ru) | Производные имидазола как модуляторы формилпептидного рецептора | |
| JP2010111691A5 (https=) | ||
| JP2016529235A5 (https=) | ||
| JP2017537940A5 (https=) | ||
| JP2017527532A5 (https=) | ||
| JP2020529994A5 (https=) | ||
| JP2016530259A5 (https=) | ||
| MX2017016611A (es) | Moduladores de tgr5 y metodos de uso de los mismos. | |
| JP2018522866A5 (https=) | ||
| JP2017511360A5 (https=) | ||
| SI2989100T1 (en) | NAFTIRIDINE DERIVATIVES USED AS ANTAGONISTS INTEGRITY OF ALFA-V-BETA-6 | |
| JP2013527242A5 (https=) | ||
| JP2013502431A5 (https=) | ||
| SI2820009T1 (en) | Serine / Threonine kinase inhibitors | |
| AR103222A1 (es) | Procedimiento para la preparación de análogos de 4-fenil-5-alcoxicarbonil-2-tiazol-2-il-1,4-dihidropirimidina | |
| JP2016515561A5 (https=) | ||
| JP2015522032A5 (https=) | ||
| JP2014511891A5 (https=) | ||
| JP2018533593A5 (https=) | ||
| JP2015531366A5 (https=) | ||
| MX2020000349A (es) | Nuevos derivados heteroaryl amida como inhibidores selectivos de histona deacetilasa 1 y 2 (hdac1/2). | |
| RU2018120242A (ru) | Хинолиновые соединения, способы их получения и их применения в качестве лекарственного средства, ингибирующего транспортер уратов | |
| JP2017537937A5 (https=) | ||
| JP2017510610A5 (https=) |